The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for children between the ages of 12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.
The Food and Drug Administration authorizes the use of the Pfizer-BioNTech COVID-19 vaccine as booster shot for children aged between 12 to 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.
The Food and Drug Administration authorizes the use of the Pfizer–BioNTech COVID-19 vaccine as abooster dose for children between theagesof12 and 15 years, becoming the world's first vaccine to be authorized as a booster shot for this age group.
